United StatesResearchers cannot yet say precisely what killed the gene therapy patient.
Last year’s death frightened scientists pursuing powerful gene treatments for brain diseases.
Capsida researchers presented investigations Friday and proposed experiments, including in monkeys, to screen future therapies for the risk.
Chief research and innovation officer Nicholas Flytzanis says the company is building a framework to predict and mitigate the risk.
How each outlet framed it
- STAT
- presents the death as a testing-framework problem, with Capsida's CRIO arguing the risk can be predicted and mitigated
Sources: STAT